Radiologic Staging and Surgical Decision-Making in the Era of Neoadjuvant Therapy for Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 25 November 2026
Special Issue Editor
2. Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy
Interests: breast; breast neoplasm; breast cancer; surgery; breast cancer surgery; axilla; axillary surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Accurate staging before neoadjuvant therapy (NAT) is pivotal for treatment planning and for guiding tailored surgical strategies in breast cancer. Advances in pre-treatment radiologic staging, including high-resolution mammography, ultrasound, MRI, PET imaging, and image-guided biopsy, have transformed the assessment of breast residual disease, nodal burden, and response to therapy. These innovations are reshaping the indications for breast-conserving surgery, mastectomy, sentinel lymph node biopsy, targeted axillary dissection, and axillary lymph node dissection after NAT. This Special Issue invites the submission of clinical, radiologic, and surgical studies that explore how modern radiologic staging techniques influence breast and axillary management, oncologic outcomes, and de-escalation strategies. Multidisciplinary contributions bridging imaging, pathology, systemic therapy, and surgery are strongly encouraged.
Dr. Damiano Gentile
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiologic staging
- neoadjuvant therapy
- breast cancer
- breast-conserving surgery
- mastectomy
- targeted axillary dissection
- sentinel lymph node biopsy
- axillary lymph node dissection
- magnetic resonance imaging
- surgical de-escalation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
